Issue Date: September 11, 2017 | Web Date: September 6, 2017
Startup sues L’Oreal over anti-aging ingredient
A religious group has filed suit against L’Oreal claiming that the cosmetics giant infringed on patents covering use of the nucleoside adenosine in wrinkle-erasing creams that the charity sells to raise money for the poor. L’Oreal says it did not violate the group’s patents.
According to the suit, filed in Delaware federal court, the Massachusetts-based Teresian Carmelites introduced Easamine, a high-end anti-wrinkle cream containing adenosine, in 2009. Easamine sales were initially strong, say the Teresians, . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society